ecrin-mdr-crcClinical2015IPD Sharing (as of February 2022): NoColorectal CancerColorectal NeoplasmsColorectal CancerColorectal NeoplasmsInterventionalhttps://newmdr.ecrin.org/Study/2184768United States5PembrolizumabMK-3475ECRIN MDRCompletedfalseStudy of Pembrolizumab in Combination With Chemotherapy for Patients With Advanced Colorectal CancerThis is a multi-institutional, single arm, open-label, phase II study, including a safety run-in cohort. No randomization or blinding involved.2015-05-152184768NCT02375672